Outlook Therapeutics enters new $100M ATM with H.C. Wainwright; cash at $7.7M

Outlook Therapeutics, Inc.

Entered into $100M at-the-market offering agreement with H.C. Wainwright & Co. as sales agent.
Prior $100M ATM with BTIG terminated effective May 12, 2026.
Preliminary cash and cash equivalents of $7.7M as of March 31, 2026 (unaudited), plus $4.5M from April 2026 direct offering.
H.C. Wainwright will receive a 3% commission on gross proceeds from shares sold under the ATM.

item 1.01 item 1.02 item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-26-060305
form_type: 8-K
ticker: OTLK
cik: 0001649989
company_name: Outlook Therapeutics, Inc.
filed_at: 2026-05-13T20:36:26+00:00
discovered_at: 2026-05-13T20:37:00.603992+00:00
generated_at: 2026-05-13T20:39:37.892062+00:00
sec_items: ["1.01", "1.02", "2.02", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-26-060305
json_url: https://secwatch.observer/filing/0001104659-26-060305.json
markdown_url: https://secwatch.observer/filing/0001104659-26-060305.md
text_url: https://secwatch.observer/filing/0001104659-26-060305.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1649989/000110465926060305/0001104659-26-060305-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1649989/000110465926060305/tm2614480d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-26-060305

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.